Solution structure of midkine, a new heparin-binding growth factor

被引:131
作者
Iwasaki, W
Nagata, K
Hatanaka, H
Inui, T
Kimura, T
Muramatsu, T
Yoshida, K
Tasumi, M
Inagaki, F
机构
[1] Tokyo Metropolitan Inst Med Sci, Bunkyo Ku, Tokyo 113, Japan
[2] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 113, Japan
[3] Peptide Inst Inc, Minoh, Osaka 562, Japan
[4] Nagoya Univ, Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 466, Japan
[5] Seikagaku Corp, Tokyo Res Inst, Tokyo 207, Japan
关键词
dimerization; growth factor; heparin binding; midkine; three-dimensional structure;
D O I
10.1093/emboj/16.23.6936
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Midkine (MK) is a 13 kDa heparin-binding polypeptide which enhances neurite outgrowth, neuronal cell survival and plasminogen activator activity. MK is structurally divided into two domains, and most of the biological activities are located on the C-terminal domain, The solution structures of the two domains were determined by NMR. Both domains consist of three antiparallel beta-strands, but the C-terminal domain has a long flexible hairpin loop where a heparin-binding consensus sequence is located. Basic residues on the beta-sheet of the C-terminal domain form another heparin-binding site, Measurement of NMR signals in the presence of a heparin oligosaccharides verified that multiple amino acids in the two sites participated in heparin binding. The MK dimer has been shown to be the active form, giving signals to endothelial cells and probably to neuronal cells, We present a head-to-head dimer model of MK. The model was supported by the results of cross-linking experiments using transglutaminase, The dimer has a fused heparin-binding site at the dimer interface of the C-terminal domain, and the heparin-binding sites on MK fit the sulfate group clusters on heparin. These features are consistent with the proposed stronger heparin-binding activity and biological activity of the dimer.
引用
收藏
页码:6936 / 6946
页数:11
相关论文
共 59 条
[1]  
Adachi Y, 1996, ONCOGENE, V13, P2197
[2]   STOICHIOMETRY OF HEPARIN-BINDING TO BASIC FIBROBLAST GROWTH-FACTOR [J].
ARAKAWA, T ;
WEN, J ;
PHILO, JS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 308 (01) :267-273
[3]  
ARIDOME K, 1995, JAP J CANC RES, V118, P88
[4]   Identification of heparin-binding sites in midkine and their role in neurite-promotion [J].
Asai, T ;
Watanabe, K ;
IchiharaTanaka, K ;
Kaneda, N ;
Kojima, S ;
Iguchi, A ;
Inagaki, F ;
Muramatsu, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (01) :66-70
[5]   MOLECULAR MODELING OF PROTEIN-GLYCOSAMINOGLYCAN INTERACTIONS [J].
CARDIN, AD ;
WEINTRAUB, HJR .
ARTERIOSCLEROSIS, 1989, 9 (01) :21-32
[6]   SUPPRESSION OF CROSS-RELAXATION EFFECTS IN TOCSY SPECTRA VIA A MODIFIED DIPSI-2 MIXING SEQUENCE [J].
CAVANAGH, J ;
RANCE, M .
JOURNAL OF MAGNETIC RESONANCE, 1992, 96 (03) :670-678
[7]   PLEIOTROPHIN TRANSFORMS NIH 3T3 CELLS AND INDUCES TUMORS IN NUDE-MICE [J].
CHAUHAN, AK ;
LI, YS ;
DEUEL, TF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :679-682
[8]   APPLICATION OF MOLECULAR-DYNAMICS WITH INTERPROTON DISTANCE RESTRAINTS TO 3-DIMENSIONAL PROTEIN-STRUCTURE DETERMINATION - A MODEL STUDY OF CRAMBIN [J].
CLORE, GM ;
BRUNGER, AT ;
KARPLUS, M ;
GRONENBORN, AM .
JOURNAL OF MOLECULAR BIOLOGY, 1986, 191 (03) :523-551
[9]   Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin [J].
Czubayko, F ;
Schulte, AM ;
Berchem, GJ ;
Wellstein, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14753-14758
[10]  
FABRI L, 1992, BIOCHEM INT, V28, P1